Vaxcyte (PCVX) News Today $34.46 -0.98 (-2.77%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PCVX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Vaxcyte, Inc. (NASDAQ:PCVX) Shares Bought by Rhumbline AdvisersRhumbline Advisers grew its holdings in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 5.5% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 181,230 shares of the company's stock after purchasing an additional 9,416 shares during the periodJune 12 at 3:40 AM | marketbeat.comCantor Fitzgerald Forecasts Vaxcyte FY2026 EarningsJune 12 at 1:45 AM | americanbankingnews.comBrokers Offer Predictions for Vaxcyte FY2026 EarningsVaxcyte, Inc. (NASDAQ:PCVX - Free Report) - Stock analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for shares of Vaxcyte in a report issued on Monday, June 9th. Cantor Fitzgerald analyst C. Gould forecasts that the company will earn ($5.62) per share for the yeJune 11 at 8:45 AM | marketbeat.comVaxcyte: Sentiment Is Pushing The Shares DownJune 10 at 1:57 PM | seekingalpha.comBrokerages Set Vaxcyte, Inc. (NASDAQ:PCVX) PT at $136.50June 8, 2025 | americanbankingnews.comVaxcyte (NASDAQ:PCVX) vs. Neumora Therapeutics (NASDAQ:NMRA) Critical ReviewJune 5, 2025 | americanbankingnews.comVaxcyte, Inc. (NASDAQ:PCVX) Given Consensus Rating of "Buy" by AnalystsShares of Vaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) have earned a consensus recommendation of "Buy" from the ten research firms that are presently covering the company, Marketbeat.com reports. Nine equities research analysts have rated the stock with a buy recommendation and one has assignedJune 5, 2025 | marketbeat.com103,683 Shares in Vaxcyte, Inc. (NASDAQ:PCVX) Purchased by Universal Beteiligungs und Servicegesellschaft mbHUniversal Beteiligungs und Servicegesellschaft mbH acquired a new position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 103,683 shares oJune 1, 2025 | marketbeat.comCalifornia State Teachers Retirement System Has $8.60 Million Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX)California State Teachers Retirement System lifted its stake in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 17.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 105,052 shares of the company's stock afJune 1, 2025 | marketbeat.comVaxcyte (NASDAQ:PCVX) Stock Price Up 5.7% - Should You Buy?Vaxcyte (NASDAQ:PCVX) Trading Up 5.7% - Still a Buy?May 30, 2025 | marketbeat.comHere’s Why Vaxcyte (PCVX) Sold Off in Q1May 27, 2025 | msn.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Boosts Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 15.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional invesMay 27, 2025 | marketbeat.comToronto Dominion Bank Invests $900,000 in Vaxcyte, Inc. (NASDAQ:PCVX)Toronto Dominion Bank purchased a new position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 11,000 shares of the company's stock, valued at approximately $900,000. OtherMay 26, 2025 | marketbeat.comFrazier Life Sciences Management L.P. Trims Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)Frazier Life Sciences Management L.P. trimmed its position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 38.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 539,405 shares of the company's stock afMay 23, 2025 | marketbeat.comMillennium Management LLC Sells 21,857 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)Millennium Management LLC lessened its stake in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 7.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 276,578 shares of the company's stock after sellMay 23, 2025 | marketbeat.comVaxcyte, Inc. (NASDAQ:PCVX) is Windsor Advisory Group LLC's 4th Largest PositionWindsor Advisory Group LLC raised its position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 72.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 39,223 shares of the company's stock after acquiringMay 22, 2025 | marketbeat.comWoodline Partners LP Increases Stake in Vaxcyte, Inc. (NASDAQ:PCVX)Woodline Partners LP raised its position in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 1.5% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,120,922 shares of the company's stock after buying an additional 16,977May 22, 2025 | marketbeat.comProShare Advisors LLC Purchases 11,729 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)ProShare Advisors LLC raised its position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 40.2% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 40,875 shares of the company's stock after acquirinMay 22, 2025 | marketbeat.comNuveen Asset Management LLC Acquires 65,713 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)Nuveen Asset Management LLC boosted its position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 14.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 529,650 shares of the company's stock aMay 22, 2025 | marketbeat.comSoleus Capital Management L.P. Buys 72,000 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)Soleus Capital Management L.P. boosted its stake in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 266.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 99,050 shares of the company's stock after buying an additional 72,00May 21, 2025 | marketbeat.com279,944 Shares in Vaxcyte, Inc. (NASDAQ:PCVX) Purchased by Twinbeech Capital LPTwinbeech Capital LP bought a new position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 279,944 shares of the company's stock, valued at approximMay 21, 2025 | marketbeat.comMan Group plc Buys 127,875 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)Man Group plc lifted its holdings in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 878.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 142,426 shares of the company's stock after purchasing aMay 21, 2025 | marketbeat.comPoint72 Asset Management L.P. Has $20.55 Million Position in Vaxcyte, Inc. (NASDAQ:PCVX)Point72 Asset Management L.P. cut its holdings in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 30.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 251,055 shares of the company's stock after selling 108,741 shares during the quarter. Point72 Asset ManagemeMay 20, 2025 | marketbeat.comMIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Boosts Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX)MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 17.2% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 76,534 shares of the company's stock after purchasMay 20, 2025 | marketbeat.comRafferty Asset Management LLC Increases Position in Vaxcyte, Inc. (NASDAQ:PCVX)Rafferty Asset Management LLC lifted its holdings in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 128.6% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 147,436 shares of the company's stock after buying an additionalMay 19, 2025 | marketbeat.comVaxcyte, Inc. (NASDAQ:PCVX) Shares Sold by Bank of America Corp DEBank of America Corp DE lowered its position in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 17.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 469,911 shares of the company's stock after selling 99,979 shares duriMay 18, 2025 | marketbeat.comVaxcyte, Inc. (NASDAQ:PCVX) Shares Sold by Polar Capital Holdings PlcPolar Capital Holdings Plc lowered its stake in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 2.2% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 973,645 shares of the company's stock after selling 22,134 shares during the period.May 17, 2025 | marketbeat.comParadigm Biocapital Advisors LP Has $116.47 Million Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX)Paradigm Biocapital Advisors LP boosted its position in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 57.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,422,787 shares of the company's stock after buying an addMay 16, 2025 | marketbeat.comParkman Healthcare Partners LLC Decreases Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX)Parkman Healthcare Partners LLC lessened its stake in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 10.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 116,138 shares of the company's stock after selling 14May 16, 2025 | marketbeat.comVaxcyte, Inc. (NASDAQ:PCVX) Stock Holdings Lifted by Nicholas Investment Partners LPNicholas Investment Partners LP increased its position in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 22.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 100,307 shares of the company's stock afteMay 16, 2025 | marketbeat.comLazard Asset Management LLC Purchases Shares of 486,764 Vaxcyte, Inc. (NASDAQ:PCVX)Lazard Asset Management LLC purchased a new stake in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 486,764 shares of the company's stock, valued at apprMay 15, 2025 | marketbeat.comBNP Paribas Financial Markets Acquires New Stake in Vaxcyte, Inc. (NASDAQ:PCVX)BNP Paribas Financial Markets acquired a new stake in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 91,265 shares of the company's stock, valued at approximately $7,471,000. BNP Paribas FMay 15, 2025 | marketbeat.com98,739 Shares in Vaxcyte, Inc. (NASDAQ:PCVX) Purchased by Hudson Bay Capital Management LPHudson Bay Capital Management LP bought a new position in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 98,739 shares of the company's stock, valued at appMay 14, 2025 | marketbeat.comVaxcyte, Inc. (NASDAQ:PCVX) Shares Acquired by Deutsche Bank AGDeutsche Bank AG increased its position in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 5.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,212,706 shares of the company's stock after aMay 14, 2025 | marketbeat.comJanus Henderson Group PLC Trims Position in Vaxcyte, Inc. (NASDAQ:PCVX)Janus Henderson Group PLC trimmed its position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 3.2% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 10,575,363 shares of the company's stock after selling 346,533 shares during the period. Janus HenderMay 13, 2025 | marketbeat.comAmeriprise Financial Inc. Purchases 366,622 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)Ameriprise Financial Inc. grew its position in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 104.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 716,773 shares of the company's stock after buying an additionalMay 13, 2025 | marketbeat.comResearch Analysts Set Expectations for Vaxcyte Q3 EarningsVaxcyte, Inc. (NASDAQ:PCVX - Free Report) - Investment analysts at Leerink Partnrs increased their Q3 2025 earnings estimates for shares of Vaxcyte in a report released on Wednesday, May 7th. Leerink Partnrs analyst D. Risinger now expects that the company will earn ($1.22) per share for the quarMay 13, 2025 | marketbeat.comEnsign Peak Advisors Inc Boosts Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)Ensign Peak Advisors Inc raised its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 7.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 586,128 shares of the company's stock after acquirMay 12, 2025 | marketbeat.comVaxcyte, Inc. (NASDAQ:PCVX) Shares Purchased by D. E. Shaw & Co. Inc.D. E. Shaw & Co. Inc. raised its holdings in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 83.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 775,653 shares of the company's stock after buying an additional 352,155 sharMay 12, 2025 | marketbeat.comVaxcyte, Inc. (NASDAQ:PCVX) Given Consensus Recommendation of "Buy" by BrokeragesVaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) has received a consensus rating of "Buy" from the ten analysts that are presently covering the stock, MarketBeat reports. Nine investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The aveMay 12, 2025 | marketbeat.comFred Alger Management LLC Sells 720,710 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)Fred Alger Management LLC reduced its position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 57.9% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 523,007 shares of the company's stock after selling 720,710 shares during the period. Fred Alger Management LLC oMay 10, 2025 | marketbeat.comVaxcyte, Inc. (NASDAQ:PCVX) Shares Sold by Driehaus Capital Management LLCDriehaus Capital Management LLC lowered its stake in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 32.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,166,833 shares of the company's stock after selling 554,463May 10, 2025 | marketbeat.comVaxcyte (NASDAQ:PCVX) Shares Acquired Rep. Gilbert Ray Cisneros, Jr.Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of Vaxcyte, Inc. (NASDAQ:PCVX). In a filing disclosed on May 06th, the Representative disclosed that they had bought between $1,001 and $15,000 in Vaxcyte stock on April 14th. The trade occurred in the Representative's "May 10, 2025 | marketbeat.comRep. Gilbert Ray Cisneros, Jr. Buys Vaxcyte, Inc. (NASDAQ:PCVX) SharesRepresentative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of Vaxcyte, Inc. (NASDAQ:PCVX). In a filing disclosed on May 06th, the Representative disclosed that they had bought between $1,001 and $15,000 in Vaxcyte stock on April 28th. The trade occurred in the Representative's "May 10, 2025 | marketbeat.comVaxcyte (PCVX) to Release Quarterly Earnings on WednesdayVaxcyte (NASDAQ:PCVX) will be releasing its Q1 2025 earnings before the market opens on Wednesday, May 14. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-14-vaxcyte-inc-stock/)May 9, 2025 | marketbeat.comDuquesne Family Office LLC Acquires 43,300 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)Duquesne Family Office LLC boosted its holdings in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 100.8% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 86,265 shares of the company's stock after acquiring an additionalMay 9, 2025 | marketbeat.comVaxcyte, Inc. (NASDAQ:PCVX) Shares Sold by Schonfeld Strategic Advisors LLCSchonfeld Strategic Advisors LLC trimmed its holdings in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 74.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 20,400 shares of the company's stock after selling 60May 9, 2025 | marketbeat.comDimensional Fund Advisors LP Raises Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)Dimensional Fund Advisors LP boosted its holdings in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 115.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 293,706 shares of the company's stock after purchasing anMay 9, 2025 | marketbeat.comVaxcyte, Inc. (NASDAQ:PCVX) Stock Position Raised by Crestline Management LPCrestline Management LP lifted its position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 88.6% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 101,035 shares of the company's stock after buying an additional 47,452 sharesMay 8, 2025 | marketbeat.comVaxcyte, Inc. (NASDAQ:PCVX) Shares Sold by Braidwell LPBraidwell LP cut its holdings in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 25.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 222,424 shares of the company's stock after selling 75,144 shareMay 8, 2025 | marketbeat.com Get Vaxcyte News Delivered to You Automatically Sign up to receive the latest news and ratings for PCVX and its competitors with MarketBeat's FREE daily newsletter. Email Address PCVX Media Mentions By Week PCVX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PCVX News Sentiment▼0.840.87▲Average Medical News Sentiment PCVX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PCVX Articles This Week▼88▲PCVX Articles Average Week Get Vaxcyte News Delivered to You Automatically Sign up to receive the latest news and ratings for PCVX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Summit Therapeutics News Today Genmab A/S News Today Intra-Cellular Therapies News Today Dr. Reddy's Laboratories News Today Moderna News Today Ascendis Pharma A/S News Today Viatris News Today Qiagen News Today Blueprint Medicines News Today Roivant Sciences News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PCVX) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaxcyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaxcyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PCVX Stock Free PCVX Stock Alerts